CMLEX
Price
$55.75
Change
-$3.01 (-5.12%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

CMLEX vs RMFCX

Header iconCMLEX vs RMFCX Comparison
Open Charts CMLEX vs RMFCXBanner chart's image
American Funds American Mutual 529E
Price$55.75
Change-$3.01 (-5.12%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
CMLEX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMLEX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMLEX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
CMLEX (104B) and RMFCX (104B) have equal amount of cash in the bank . CMLEX (1.73) and RMFCX (1.69) have matching dividends . CMLEX was incepted earlier than RMFCX: CMLEX (23 years) vs RMFCX (23 years). CMLEX (25.00) and RMFCX (25.00) have comparable annual turnover. CMLEX (250) and RMFCX (250) have matching initial minimum investment requirements. CMLEX (12.69) and RMFCX (12.63) have marching annual gain over last year. CMLEX (40.81) and RMFCX (40.39) have equivalent 5 years return.
CMLEXRMFCXCMLEX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD11.48911.423101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets104B104B100%
Annual Yield % from dividends1.731.69102%
Returns for 1 year12.6912.63101%
Returns for 3 years14.3714.16102%
Returns for 5 years40.8140.39101%
Returns for 10 years77.4261.84125%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc